Atossa Therapeutics, Inc. (ATOS) vs Estrella Immunopharma, Inc. (ESLA)

Atossa Therapeutics, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and Estrella Immunopharma, Inc. are of similar size ($20.5M and $20.5M). Across the 8 metrics below, Estrella Immunopharma, Inc. leads on 5 and Atossa Therapeutics, Inc. on 3.

Valuation

Metric ATOS ESLA Biotechnology median
P/E n/m n/m 7.88
P/S 422.12 n/m 11.47
P/B 0.63 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.24 n/m 0.74
EV/Sales (231.34) n/m 10.73
Earnings yield (230.65%) (50.81%) (28.84%)
Free cash flow yield (211.50%) (45.47%) (23.03%)

Profitability

Metric ATOS ESLA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (89.23%) 148.05% (57.72%)
Return on assets (77.91%) (416.74%) (49.22%)
Return on invested capital (3,918.83%) 0.00% 0.00%

Growth

Metric ATOS ESLA Biotechnology median
Revenue growth (TTM) (93.66%) — 5.64%
EPS growth (last fiscal year) (34.73%) (188.78%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATOS ESLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.69 0.20 4.73
Net debt to EBITDA 1.12 0.11 0.96

Dividend

Metric ATOS ESLA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ATOS ESLA Biotechnology median
Market cap 20.46m 20.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack